Skip to main navigation

Search

Main navigation

  • Our Company
    • Overview
    • Leadership
    • Board of Directors
  • Programs
    • IBD
    • Nash
    • Pipeline
    • Publications
  • Patients
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • Investor Resources
      • Email Alerts
      • IR Contact
      • FAQs
  • News
  • Careers
  • Contact
SEC Filing Details

SEC Filing Details

Investor Relations

  • Investor Relations
    • Overview
    • News Releases
    • Events & Presentations
      • Presentations
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • Investor Resources
      • Email Alerts
      • Contact IR
      • FAQs

Document Details

Form
8-K
Filing Date
Mar 3, 2023
Document Date
Feb 27, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Metacrine, Inc.
Issuer
Metacrine, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
© 2023 Metacrine, Inc.   |   3985 Sorrento Valley Blvd., Suite C, San Diego, CA 92121

Main navigation

  • Our Company
    ▼
    • Overview
    • Leadership
    • Board of Directors
  • Programs
    ▼
    • IBD
    • Nash
    • Pipeline
    • Publications
  • Patients
  • Investors
    ▼
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
      ▼
      • Governance Documents
      • Committee Composition
    • Financials & Filings
      ▼
      • SEC Filings
      • Quarterly Results
    • Investor Resources
      ▼
      • Email Alerts
      • IR Contact
      • FAQs
  • News
  • Careers
  • Contact